Modulation of skeletal muscle performance and SERCA by exercise and adiponectin gene therapy in insulin-resistant rat

DNA and Cell Biology

Volumn 32, Issue 7, 2013, Pages 378-385

  Safwat, Yasmeen ^a   Yassin, Nadia ^a,b   Gamal El Din, Maha ^a,b   Kassem, Lobna ^a,b  

^a German University in Cairo   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; LIPOFECTAMINE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; GENE THERAPY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE INDEX; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KINESIOTHERAPY; LIPOSOMAL GENE DELIVERY SYSTEM; MALE; MONOTHERAPY; MUSCLE CONTRACTILITY; MUSCLE EXERCISE; MUSCLE FUNCTION; MUSCULOSKELETAL SYSTEM PARAMETERS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PEAK TETANIC TENSION; PEAK TWITCH TENSION; PRIORITY JOURNAL; RAT; RELAXATION TIME; SKELETAL MUSCLE; SWIMMING; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ADIPONECTIN; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GENETIC THERAPY; GLUCOSE TRANSPORTER TYPE 4; INSULIN RESISTANCE; MALE; MUSCLE, SKELETAL; PHYSICAL CONDITIONING, ANIMAL; RATS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; TREATMENT OUTCOME;

RATTUS;

EID: 84879914918     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2012.1919     Document Type: Article

References (58)

1. Abel, E.D., et al. (2001). Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729-733. (Pubitemid 32144519)
2. Berg, A.H., et al. (2001). The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7, 947-953. (Pubitemid 32756433)
3. Berger, J., and Moller, D.E. (2002). The mechanisms of action of PPARs. Annu Rev Med 53, 409-435. (Pubitemid 34177889)
4. Boule, N.G., et al. (2005). Effects of exercise training on glucose homeostasis: the HERITAGE Family Study. Diabetes Care 28, 108-114. (Pubitemid 40095791)
5. Buettner, R., et al. (2006). Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 36, 485-501. (Pubitemid 43904942)
6. Byrd, S.K., Bode, A.K., and Klug. G.A. (1989). Effects of exercise of varying duration on sarcoplasmic reticulum function. J Appl Physiol 66, 1383-1389. (Pubitemid 19091374)
7. Cameron, N.E., Cotter, M.A., and Robertson, S. (1989). Contractile properties of cardiac papillary muscle in streptozotocin-diabetic rats and the effects of aldose reductase inhibition. Diabetologia 32, 365-370. (Pubitemid 19171841)
8. Cameron, N.E., Cotter, M.A., and Robertson, S. (1990). Changes in skeletal muscle contractile properties in streptozocin-induced diabetic rats and role of polyol pathway and hypoinsulinemia. Diabetes 39, 460-465. (Pubitemid 20111429)
9. Ceddia, R.B., et al. (2005). Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 48, 132-139. (Pubitemid 40174665)
10. Cline, G.W., et al. (1999). Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes. N Engl J Med 341, 240-246. (Pubitemid 29334522)
11. Cotter, M.A., et al. (1993). Polyol pathway-related skeletal muscle contractile and morphological abnormalities in diabetic rats. Exp Physiol 78, 139-155. (Pubitemid 23135260)
12. Crow, M.T., and Kushmerick, M.J. (1983). Correlated reduction of velocity of shortening and the rate of energy utilization in mouse fast-twitch muscle during a continuous tetanus. J Gen Physiol 82, 703-720. (Pubitemid 14211709)
13. Dawson, M.J., Gadian, D.G., and Wilkie, D.R. (1980). Mechanical relaxation rate and metabolism studied in fatiguing muscle by phosphorus nuclear magnetic resonance. J Physiol 299, 465-484. (Pubitemid 10113768)
14. de Haan, A., Jones, D.A., and Sargeant, A.J. (1989). Changes in velocity of shortening, power output and relaxation rate during fatigue of rat medial gastrocnemius muscle. Pflugers Arch 413, 422-428. (Pubitemid 19059648)
15. de Lemos, E.T., et al. (2007). Exercise training is associated with improved levels of C-reactive protein and adiponectin in ZDF (type 2) diabetic rats. Med Sci Monit 13, BR168-BR174. (Pubitemid 47359097)
16. Duncan, G.E., et al. (2003). Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. Diabetes Care 26, 557-562. (Pubitemid 36929307)
17. Ferrannini, E., et al. (1999). Insulin: new roles for an ancient hormone. Eur J Clin Invest 29, 842-852. (Pubitemid 29479102)
18. Gault, V.A., et al. (2002). Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide. Biochem Biophys Res Commun 290, 1420-1426. (Pubitemid 34687416)
19. Gollnick, P.D., et al. (1991). Elongation of skeletal muscle relaxation during exercise is linked to reduced calcium uptake by the sarcoplasmic reticulum in man. Acta Physiol Scand 142, 135-136.
20. Hawley-Nelson, P., et al. (1993). LipofectAMINE Reagent: a new, higher efficiency polycationic liposome transfection reagent. Focus 15, 73-79.
21. Kadowaki, T., and Yamauchi, T. (2005). Adiponectin and adiponectin receptors. Endocr Rev 26, 439-451. (Pubitemid 40686653)
22. Kadowaki, T., et al. (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116, 1784-1792. (Pubitemid 44033298)
23. Kashyap, S.R., and Defronzo, R.A. (2007). The insulin resistance syndrome: physiological considerations. Diab Vasc Dis Res 4, 13-19. (Pubitemid 46649069)
24. Knowler, W.C., et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393-403. (Pubitemid 34437694)
25. Krause, M.P., et al. (2008b). Adiponectin is expressed by skeletal muscle fibers and influences muscle phenotype and function. Am J Physiol Cell Physiol 295, C203-C212. (Pubitemid 352755800)
26. Kubo, H., et al. (2003). Differential effects of exercise training on skeletal muscle SERCA gene expression. Med Sci Sports Exerc 35, 27-31. (Pubitemid 36084136)
27. Li, S., et al. (2009). Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-nalysis. JAMA 302, 179-188.
28. MacLennan, D.H., et al. (1985). Amino-acid sequence of a Ca2 + + Mg2 +-dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence. Nature 316, 696-700. (Pubitemid 16239341)
29. Marie, J.C., et al. (2001). Defective glucose-dependent cytosolic Ca2 + handling in islets of GK and nSTZ rat models of type 2 diabetes. J Endocrinol 169, 169-176.
30. Martin, I.K., Katz, A., and Wahren J. (1995). Splanic and muscle metabolism during exercise in NIDDM patients. Am J Physiol Endocrinol Metab 269, E583-E590.
31. Matthews, D.R., et al. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419. (Pubitemid 15018832)
32. Narayan, K.M., et al. (2000). Translation research for chronic disease: the case of diabetes. Diabetes Care 23, 1794-1798.
33. Paulus, S.F., and Grossie, J. (1983). Skeletal muscle in alloxan diabetes. A comparison of isometric contractions in fast and slow muscle. Diabetes 32, 1035-1039. (Pubitemid 14225121)
34. Payne, A.M., et al. (2004). External Ca(2 +)-dependent excitation-contraction coupling in a population of ageing mouse skeletal muscle fibres. J Physiol 560(Pt 1), 137-155. (Pubitemid 39406022)
35. Pedersen, B.K. (2006). The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem 42, 105-117
36. Peijie, C., et al. (2004). Effects of chronic and acute training on glucocorticoid receptors concentrations in rats. Life Sci 75, 1303-1311. (Pubitemid 38845029)
37. Petridou, A., et al. (2007). Long-term exercise increases the DNA binding activity of peroxisome proliferator-activated receptor gamma in rat adipose tissue. Metabolism 56, 1029-1036. (Pubitemid 47021165)
38. Ploug, T., Stallknecht, B.M., Pedersen, O., Kahn, B.B., Ohkuwa, T., Vinten, J., and Galbo, H. (1990). Effect of endurance training on glucose transport capacity and glucose transporter expression in rat skeletal muscle. Am J Physiol 259 (6 Pt 1), E778-E786.
39. Ren, J.M., et al. (1994). Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle. J Biol Chem 269, 14396-14401.
40. Reynolds, T.H.T., et al. (1997). Effects of exercise training on glucose transport and cell surface GLUT-4 in isolated rat epitrochlearis muscle. Am J Physiol 272(2 Pt 1), E320-E325.
41. Roeschlau, P., Bernt, E., and Gruber, W. (1974). Enzymatic de-termination of total cholesterol in serum. Z Klin Chem Klin Biochem 12, 226.
42. Russell, D.M., et al. (1984). The effect of fasting and hypocaloric diets on the functional and metabolic characteristics of rat gastrocnemius muscle. Clin Sci (Lond) 67, 185-194.
43. Saha, A.K., et al. (2004). Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem Biophys Res Commun 314, 580-585. (Pubitemid 38084758)
44. Saltiel, A.R., and Olefsky, J.M. (1996). Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45, 1661-1669. (Pubitemid 26398943)
45. Shih, P., Hawley-Nelson, P., and Joel, A.J. (1997). Enhancement of lipid cationic transfections in the presence of serum. Focus 19, 52.
46. Sigal, R.J., et al. (2004). Physical activity/exercise and type 2 diabetes. Diabetes Care 27, 2518-2539. (Pubitemid 39281418)
47. Sullivan, P.W., et al. (2005). Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 28, 1599-1603. (Pubitemid 40923071)
48. Thompson, P.D. (2003). Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease. Arterioscler Thromb Vasc Biol 23, 1319-1321. (Pubitemid 36994517)
49. Tomas, E., et al. (2002). Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase ac-tivation. Proc Natl Acad Sci USA99, 16309-16313. (Pubitemid 35462791)
50. Tsuchida, A., Yamauchi, T., and Kadowaki, T. (2005). Nuclear receptors as targets for drug development: molecular mecha-nisms for regulation of obesity and insulin resistance by per-oxisome proliferator-activated receptor gamma, CREB-binding protein, and adiponectin. J Pharmacol Sci 97, 164-170. (Pubitemid 40410254)
51. Ueno, N., et al. (1997). Effects of swimming training on brown-adipose-tissue activity in obese ob/ob mice: GDP binding and UCP m-RNA expression. Res Commun Mol Pathol Pharmacol 95, 92-104. (Pubitemid 27098252)
52. Viru, M. (1994). Differences in effects of various training regimens on metabolism of skeletal muscles. J Sports Med Phys Fitness 34, 217-227. (Pubitemid 24372506)
53. Wahlefeld, A. (1974). Triacylglycerol Determination After Enzymatic Hydrolysis. Method of Enzymatic Analysis. Hu Berger ed., 2nd English ed translated from 3rd German ed Verage. (Press, Inc., NY and London), p. 4.
54. Wold, L.E., et al. (2005). Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats. J Mol Cell Cardiol 39, 297-307. (Pubitemid 40995019)
55. Wright, D.C., et al. (2004). Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes 53, 330-335. (Pubitemid 38174547)
56. Yamauchi, T., et al. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 1288-1295. (Pubitemid 35373562)
57. Yoon, M.J., et al. (2006). Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMPactivated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55, 2562-2570.
58. Zisman, A., et al. (2000). Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6, 924-928. (Pubitemid 30644753)